Accelerating the Development of Cell and Gene Therapies: From Discovery to Biomanufacture

Oxgene, a WuXi Advanced Therapies (WuXi ATU) company, provides cell and gene therapy pioneers around the world with technologies, automation platforms, and service solutions to advance their preclinical research and accelerate their timelines to good manufacturing practice (GMP) manufacturing. WuXi ATU, a global contract testing, development, and manufacturing organization (CTDMO), offers world-class, integrated GMP manufacturing and testing platforms to reduce time to market, while maintaining high titers, high levels of quality assurance, and full regulatory compliance. Together, our complete end-to-end cell and gene therapy solutions support pioneering companies to be first in the race to deliver breakthrough therapies to patients.

Fill out the form below to read the complete capabilities review and learn more about end-to-end cell and gene therapy solutions now.